Wall Street Experts
ver. ZuMIgo(08/25)
Poseida Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 151
EBIT TTM (mln): -52
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
10 |
3 |
0 |
0 |
0 |
0 |
130 |
65 |
Przychód Δ r/r |
0.0% |
-69.4% |
-100.0% |
0.0% |
0.0% |
inf% |
417217.1% |
-50.4% |
Marża brutto |
100.0% |
100.0% |
0.0% |
-inf% |
-inf% |
-14472.0% |
96.0% |
100.0% |
EBIT (mln) |
-5 |
-20 |
-42 |
-86 |
-0 |
-0 |
-60 |
-130 |
EBIT Δ r/r |
0.0% |
260.9% |
113.5% |
103.7% |
-99.9% |
11.7% |
42291.3% |
116.0% |
EBIT (%) |
-55.8% |
-658.9% |
0.0% |
0.0% |
0.0% |
-452.7% |
-46.0% |
-200.2% |
Koszty finansowe (mln) |
0 |
1 |
2 |
4 |
0 |
0 |
6 |
-9 |
EBITDA (mln) |
-5 |
-21 |
-41 |
-75 |
-0 |
-0 |
-57 |
-130 |
EBITDA(%) |
-53.5% |
-699.5% |
0.0% |
0.0% |
0.0% |
-389.3% |
-43.8% |
-200.2% |
Podatek (mln) |
-1 |
-1 |
-0 |
6 |
-3 |
-5 |
1 |
-0 |
Zysk Netto (mln) |
-5 |
-20 |
-44 |
-93 |
2 |
4 |
-64 |
-123 |
Zysk netto Δ r/r |
0.0% |
329.8% |
125.8% |
108.6% |
-102.6% |
79.6% |
-1553.3% |
92.9% |
Zysk netto (%) |
-46.8% |
-658.7% |
0.0% |
0.0% |
0.0% |
14097.8% |
-49.1% |
-190.8% |
EPS |
-0.0771 |
-0.49 |
-1.24 |
-2.33 |
0.0681 |
0.0708 |
-0.89 |
-0.0014 |
EPS (rozwodnione) |
-0.0771 |
-0.49 |
-1.24 |
-2.33 |
0.0681 |
0.0708 |
-0.89 |
-0.0014 |
Ilośc akcji (mln) |
59 |
40 |
36 |
40 |
36 |
62 |
72 |
90,185 |
Ważona ilośc akcji (mln) |
59 |
40 |
36 |
40 |
36 |
62 |
72 |
90,185 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |